57
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Self-administration of vaginal misoprostol after mifepristone for termination of pregnancy: Patient acceptability

, &
Pages 679-681 | Published online: 02 Jul 2009

References

  • Ashok P W, Templeton A, Wagaarachchi P T, Flett G M. Factors affecting the outcome of early medical abortion; a review of 4132 consecutive cases. British Journal of Obstetrics and Gynaecology 2002; 109: 1281–1289
  • Aubeny E, Chatellier G. A randomised comparison of mifepristone and self-administered oral or vaginal misoprostol for early abortion. European Journal of Contraception and Reproductive Health Care 2000; 5: 171–176
  • BPAS press release. Early medical abortion made easier by BPAS. Stratford-upon-Avon: British Pregnancy Advisory Service. 8 February, 2001
  • Clark S, Ellertson C, Winikoff B. Is medical abortion acceptable to all American women: the impact of sociodemographic characteristics on the acceptability of Mifepristone-Misoprostol abortion. Journal of the American Medical Women's Association 2000; 55: 177–182
  • Dagousset I, Fourrier E, Aubent E, Taurelle R. Use of Misoprostol for medical abortion: a trial of acceptability for home use. Gynecology Obstetrics and Fertility 2004; 32: 28–33
  • DoH. Abortion statistics; England and Wales 2003. DoH, London 2004, Statistical Bulletin 2003/23
  • Elu B, Pearlman E, Sorhaindo A, Simonds W, Westhoff C. In depth interviews with medical abortion clients: thoughts on the method and home administration of Misoprostol. Journal of the American Medical Women's Association 2000; 53: 169–172
  • Elu B, Hajri S, Ngoc N N, Ellerston C, Slama C B, Pearlman E, et al. Can women in less-developed countries use a simplified medical abortion?. Lancet 2001; 357: 1402–1405
  • Guengant J P, Bangou J, Elu B, Ellerston C. Mifepristone-misoprostol medical abortion: home administration of misoprostol in Guadeloupe. Contraception 1999; 60: 167–172
  • Kiran U, Amin P, Penketh R J. Self administration of misoprostol for termination of pregnancy: safety and efficacy. Journal of Obstetrics and Gynaecology 2004; 24: 155–156
  • Ngoc N T, Nhan V Q, Blum J, Mai T T, Durocher J M, Winikoff B. Is home-based administration of prostaglandin safe and feasible for medical abortion? Results from a multisite study in Vietnam. British Journal of Obstetrics and Gynaecology 2004; 111: 814–819
  • Schaff E A, Stadalius L S, Eisinger S H, Franks P. Vaginal Misoprostol self administered at home after Mifepristone (RU 486) for abortion. Journal of Family Practice 1997; 44: 353–360
  • Schaff E A, Eisenger S H, Stadalius L S, Franks P, Gore B Z, Poppema S. Low-dose mifepristone 200mg and vaginal misoprostol for abortion. Contraception 1999; 59: 1–6
  • Schaff E A, Fielding S L, Westhoff C, Ellertson C, Eisinger S H, Stadalius L S, et al. Vaginal misoprostol administered 1, 2 or 3 days after mifepristone for early medical abortion: A randomised trial. Journal of the American Medical Association 2000; 284: 1948–1953

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.